Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on BIT. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel dibromo-amino silica gel method achieves >99% selectivity and >99.8% purity for SGLT-2 inhibitors, significantly reducing waste and manufacturing costs.
Patent CN101723890B reveals novel arylthiourea compounds with superior VEGFR-2 inhibition. Discover cost-effective synthesis and supply chain advantages for oncology drug development.
Explore advanced arylthiourea synthesis for VEGFR-2 inhibition. Discover cost-effective manufacturing routes and superior safety profiles for oncology drug development.
Patent CN1377337A details a novel route for COX-2 inhibitor intermediates via lactam hydrolysis. Offers cost reduction in API manufacturing and scalable supply chain solutions.
Advanced synthesis of MK2 inhibitor intermediates via patent CN116670142A. Enhanced yield and purity for pharmaceutical manufacturing supply chains.
Patent CN109134485B reveals a high-yield isosorbide synthesis using 1,4-sorbitan and solid acids. Discover cost-effective, scalable bio-based manufacturing solutions.
Advanced synthesis of MMP inhibitors via novel Friedel-Crafts and Sonogashira coupling. Cost-effective manufacturing for high-purity pharmaceutical intermediates.
Patent CN1495164A details a Rh-catalyzed route to chiral lactones. Offers high ee and scalable process for MMP inhibitor intermediates.
Patent CN112661744B reveals an isothermal purification method for Esomeprazole Sodium, achieving >99.5% purity with minimal R-enantiomer. Ideal for reliable pharmaceutical intermediate supply chains.
Novel 3-step synthesis for Dapagliflozin ensures high yield and purity. Cost-effective manufacturing solution for global pharmaceutical supply chains.
Patent CN112341351B reveals a high-yield route for 2-amino-4-bromo-3-fluoro-5-iodobenzamide, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN108299426B reveals a KI-catalyzed route for [1,2,4]-triazolo[4,3-a]pyridines, offering cost reduction and green chemistry advantages for pharmaceutical manufacturing.
Novel photocatalytic route for CDK2 inhibitor intermediates. High yield, room temperature fluorination. Cost-effective manufacturing solution.
Novel 2-phenyl quinazoline derivatives targeting telomerase with high selectivity and low toxicity. Efficient synthesis routes for pharmaceutical intermediates.
Novel one-pot method for (5-bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone. High purity, reduced steps, eco-friendly process for API manufacturing.
Novel patent CN113880704B offers high-purity 18O-labeled aldehydes. Reduces heavy oxygen water loss and simplifies scale-up for pharmaceutical intermediates manufacturing globally.
Novel two-step route for 18O-labeled aldehydes ensures high purity and reduced isotope loss for scalable pharmaceutical intermediate manufacturing and research applications.
Novel patent CN104045596A offers high-purity etoricoxib intermediate synthesis with improved yield and cost efficiency for reliable pharmaceutical intermediate supplier partnerships.
Novel nickel-catalyzed route for LCZ696 intermediate. Reduces toxic reagents, enhances supply chain reliability for pharmaceutical manufacturing partners globally.
Patent CN1656077A reveals a novel Julia-Kocienski route for statin intermediates. Discover cost-effective manufacturing and scalable supply chain solutions.